You're describing a **steroid** with a specific chemical structure. Here's a breakdown:
* **(5α)-:** This indicates the configuration at carbon 5 is in the alpha position. Steroids have multiple rings, and this detail affects the molecule's 3D shape.
* **23-methyl-:** A methyl group (CH3) is attached at carbon 23.
* **4-aza-:** A nitrogen atom replaces a carbon atom at position 4 in the steroid ring system.
* **21-norchol-:** This indicates a modification to the cholane backbone. Nor means a carbon atom has been removed, specifically at position 21.
* **1-ene-:** A double bond exists between carbons 1 and 2.
* **3,20-dione:** There are two ketone functional groups (C=O) at carbons 3 and 20.
**Importance in Research:**
This particular steroid is a derivative of **androstenedione**, a naturally occurring hormone. While it's not found naturally, it's synthesized and studied for several reasons:
* **Pharmacological Activity:** Modifications like the nitrogen at position 4 and the removal of carbon 21 can alter the molecule's ability to bind to hormone receptors. This could create compounds with new and interesting pharmacological effects.
* **Probing Biological Processes:** By studying how this synthetic steroid interacts with biological systems, researchers gain insights into the mechanisms of hormone action and potential targets for drug development.
* **Investigating Structure-Activity Relationships:** By systematically modifying the steroid structure and observing its effects, researchers can develop a better understanding of how molecular structure impacts biological activity.
**Specific Research Applications:**
* **Drug Discovery:** Compounds with similar structures are explored for their potential in treating conditions like cancer, inflammation, and hormone-related disorders.
* **Hormone Research:** This molecule might be used to investigate the role of androgen receptors in various biological processes.
* **Chemistry Research:** Studying the synthesis and modification of this steroid could contribute to the development of new synthetic techniques.
**Important Note:** To be truly helpful, we need more context. Is this a specific molecule being investigated in a particular study? Knowing the specific research area will help me provide more detailed and relevant information.
(5alpha)-23-methyl-4-aza-21-norchol-1-ene-3,20-dione: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 6918127 |
CHEMBL ID | 575781 |
SCHEMBL ID | 8156652 |
MeSH ID | M0208261 |
Synonym |
---|
mk-963 |
mk-0963 |
l-654066 |
mk 0963 |
CHEMBL575781 |
(1s,3as,3bs,5ar,9ar,9bs,11as)-9a,11a-dimethyl-1-(3-methylbutanoyl)-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinolin-7-one |
xec7u2o6sc , |
4-aza-21-norchol-1-ene-3,20-dione, 23-methyl-, (5alpha)- |
l-654,066 |
unii-xec7u2o6sc |
(5alpha)-23-methyl-4-aza-21-norchol-1-ene-3,20-dione |
l 654066 |
103497-68-3 |
2h-indeno(5,4-f)quinolin-2-one, 1,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-7-(3-methyl-1-oxobutyl)-, (4ar,4bs,6as,7s,9as,9bs,11ar)- |
SCHEMBL8156652 |
mk0963 |
Q27293805 |
AKOS040749871 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID442239 | Inhibition of human 5 alpha reductase assessed as -log of ratio of IC50 of drug to the IC50 of reference compound | 2010 | European journal of medicinal chemistry, Feb, Volume: 45, Issue:2 | 3D-QSAR studies on unsaturated 4-azasteroids as human 5alpha-reductase inhibitors: a self organizing molecular field analysis approach. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.12) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (40.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 3 (60.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |